1966
DOI: 10.1177/14.5.434
|View full text |Cite
|
Sign up to set email alerts
|

TWo METHODS FOR THE DEMONSTRATION OF NORADRENALINE-CONTAINING ADRENAL MEDULLARY CELLS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1968
1968
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…Hopsu and Mäkinen’s staining is one of the classical methods. This method is based on the reduction of NBT salt at alkaline pH essentially as in the demonstration of sulfhydryl groups (Hopsu and Mäkinen 1966). To determine the cell type of hematoxylin-stained chromaffin cells, we used this method.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Hopsu and Mäkinen’s staining is one of the classical methods. This method is based on the reduction of NBT salt at alkaline pH essentially as in the demonstration of sulfhydryl groups (Hopsu and Mäkinen 1966). To determine the cell type of hematoxylin-stained chromaffin cells, we used this method.…”
Section: Resultsmentioning
confidence: 99%
“…We followed Hopsu and Mäkinen’s staining method (Hopsu and Mäkinen 1966) except for the buffer system. In brief, paraffin sections were deparaffinized in xylene and ethanol.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, three tests quoted by Barka and Anderson (1963) were used: diazotized saffranin for 5- HT (Lillie et al 1953), the astra-blue method for acid mucopolysaccharides (Pioch 1958), and the potassium iodate method for adrenalin (Hillarp and Hokfelt 1955). The presence of noradrenalin was determined by the tetrazolium and ferric-ferricyanide reactions (Hopsu and Makinen 1966) after glutaraldehyde fixation. The same fixation preceded tests for indoles (Solcia et al 1966).…”
Section: Methodsmentioning
confidence: 99%
“…PC18, a second APN inhibitor, inhibits APN 2150-fold (Ki = 8 nM) more strongly than APA and 125-fold more strongly than aminopeptidase B (EC 3.4.11.6). The latter is another monozinc aminopeptidase that preferentially cleaves N-terminal basic residues [59,60]. These compounds were used in vivo [32,61] to study the metabolism of brain angiotensins (Fig.…”
Section: Identification Of the In Vivo Metabolic Pathways Of Angii Anmentioning
confidence: 99%